Null phenotype for cytochrome P450 2B2 in the rat results from a deletion of its structural gene

Curtis J. Omiecinski, Richard Ramsden, Arfaan Rampersaud, Frederick G. Walz

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


The absence of phenobarbital (PB)-inducible cytochrome P450 2B2 (CYP2B2) in hepatic microsomes from Marshall 520 (M520) and Wistar Munich (WM) inbred strains of rat was previously reported [Biochem. Genet. 25:527-534 (1987)], and it was subsequently shown for M520 rats that corresponding CYP2B2 mRNA was not detected in hepatic extracts from either control or PB-treated animals [DNA 8:29-37 (1989)]. In the present study, solution hybridization was used to quantify PB-induced CYP2B2 and CYP2B1 mRNAs in livers from M520, WM, and outbred Sprague-Dawley rats, as well as additional inbred strains that express all known electrophoretic phenotypes for both of these closely related isozymes. Amounts of these mRNAs were also measured for F1 and F2 progenies of crosses involving M520 rats. The results indicated that the extent of PB induction of both isozymes appears to be independent of the electrophoretic phenotype. It was also shown that the null phenotype for CYP2B2 observed in M520 rats results from a mutation of a single autosomal gene and is inherited codominantly, regarding protein and mRNA phenotypes. Analyses of restriction digests and specific polymerase chain reaction products of hepatic DNAs revealed that the basis for the null phenotype of CYP2B2 in M520 and WM rats was a deletion of the CYP2B2 gene.

Original languageEnglish (US)
Pages (from-to)249-256
Number of pages8
JournalMolecular pharmacology
Issue number2
StatePublished - Aug 1992

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology


Dive into the research topics of 'Null phenotype for cytochrome P450 2B2 in the rat results from a deletion of its structural gene'. Together they form a unique fingerprint.

Cite this